Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)

Launched by NANJING MEDICAL UNIVERSITY · Dec 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying psoriatic arthritis (PsA), a condition that causes inflammation in the joints and skin. Researchers are using a special imaging technique called Power Doppler ultrasonography (PDUS) to better understand how active the disease is and how well treatments are working. The goal is to gather information on disease activity and potential bone damage in patients with PsA.

To participate in this study, you need to be diagnosed with PsA according to specific criteria and be able to follow the visit schedule and treatment plan. Unfortunately, if you've had other types of arthritis in the past year, are pregnant or breastfeeding, or have certain medical conditions, you may not be eligible. If you join the study, you can expect regular check-ups and tests to monitor your condition, all while being a part of important research that could improve care for people with psoriatic arthritis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • PsA patients as defined by CASPAR criteria
• • Patients must be able to comply with the visit schedule, treatment plan, laboratory tests and other study procedures
• • Patients must be given informed consent
• Exclusion Criteria:
• • History of other arthritis within the last 12 months
• • Concomitant disease with acute or chronic infectious diseases
• • Pregnancy or laction
• • Poorly tolerated with venipuncture required for blood sampling during the study